Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Katja Kiseljak‐Vassiliades"'
Autor:
Emily Warmington, Gabrielle Smith, Vasileios Chortis, Raimunde Liang, Juliane Lippert, Sonja Steinhauer, Laura-Sophie Landwehr, Constanze Hantel, Katja Kiseljak-Vassiliades, Margaret E Wierman, Barbara Altieri, Paul A Foster, Cristina L Ronchi
Publikováno v:
Endocrine Connections, Vol 13, Iss 1, Pp 1-12 (2023)
Adrenocortical carcinoma (ACC) is an aggressive malignancy with limited treatment options. Polo-like kinase 1 (PLK1) is a promising drug target; PLK1 inhibitors (PLK1i) have been investigated in solid cancers and are more effective in TP53-mutated ca
Externí odkaz:
https://doaj.org/article/e4efec62f5f64d8ab3df24cff09f9c14
Autor:
Juan A. Marín-Jiménez, Anna Capasso, Matthew S. Lewis, Stacey M. Bagby, Sarah J. Hartman, Jeremy Shulman, Natalie M. Navarro, Hui Yu, Chris J. Rivard, Xiaoguang Wang, Jessica C. Barkow, Degui Geng, Adwitiya Kar, Ashley Yingst, Dejene M. Tufa, James T. Dolan, Patrick J. Blatchford, Brian M. Freed, Raul M. Torres, Eduardo Davila, Jill E. Slansky, Roberta Pelanda, S. Gail Eckhardt, Wells A. Messersmith, Jennifer R. Diamond, Christopher H. Lieu, Michael R. Verneris, Jing H. Wang, Katja Kiseljak-Vassiliades, Todd M. Pitts, Julie Lang
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Over the past decade, immunotherapies have revolutionized the treatment of cancer. Although the success of immunotherapy is remarkable, it is still limited to a subset of patients. More than 1500 clinical trials are currently ongoing with a goal of i
Externí odkaz:
https://doaj.org/article/6424fe4cd62341bb904d284bc361adfc
Senescence-induced immune remodeling facilitates metastatic adrenal cancer in a sex-dimorphic manner
Autor:
Kate M. Warde, Lorenzo J. Smith, Lihua Liu, Chris J. Stubben, Brian K. Lohman, Parker W. Willett, Julia L. Ammer, Guadalupe Castaneda-Hernandez, Sikiru O. Imodoye, Chenge Zhang, Kara D. Jones, Kimber Converso-Baran, H. Atakan Ekiz, Marc Barry, Michael R. Clay, Katja Kiseljak-Vassiliades, Thomas J. Giordano, Gary D. Hammer, Kaitlin J. Basham
Publikováno v:
Nature Aging.
Autor:
Lauren Fishbein, Katja Kiseljak-Vassiliades, Margaret E. Wierman, Debbie L. Cohen, Katherine L. Nathanson, Christopher D. Raeburn, Maria Albuja-Cruz, Carrie B. Marshall, Nikita Pozdeyev, Kristin Panwell, Katrina Koc, Nathaniel Alzofon
Table S1 has the RNA-Seq sample names and raw counts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11eb49a6bb7f8f13dd356fe0443a1f83
https://doi.org/10.1158/1541-7786.22526510
https://doi.org/10.1158/1541-7786.22526510
Autor:
Lauren Fishbein, Katja Kiseljak-Vassiliades, Margaret E. Wierman, Debbie L. Cohen, Katherine L. Nathanson, Christopher D. Raeburn, Maria Albuja-Cruz, Carrie B. Marshall, Nikita Pozdeyev, Kristin Panwell, Katrina Koc, Nathaniel Alzofon
Metastatic disease in pheochromocytomas and paragangliomas (PCC/PGL) is not well-understood. The Cancer Genome Atlas discovered recurrent MAML3 fusion genes in a subset of tumors that lacked known germline or somatic driver mutations and were associa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::674750c2959d14a74db7c61f10663f20
https://doi.org/10.1158/1541-7786.c.6545123.v1
https://doi.org/10.1158/1541-7786.c.6545123.v1
Autor:
Lauren Fishbein, Katja Kiseljak-Vassiliades, Margaret E. Wierman, Debbie L. Cohen, Katherine L. Nathanson, Christopher D. Raeburn, Maria Albuja-Cruz, Carrie B. Marshall, Nikita Pozdeyev, Kristin Panwell, Katrina Koc, Nathaniel Alzofon
MAML3 overexpression has no effect on proliferation or apoptotic signaling. SK-N-SH, QGP-1 and BON-1 transfected with FL or dEx1 MAML3 and showed A) no increase in proliferation by BrdU assay when grown in full serum media for 72 hours and B) no incr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ce28523047fb39b8d33c486783b1d49
https://doi.org/10.1158/1541-7786.22526531.v1
https://doi.org/10.1158/1541-7786.22526531.v1
Publikováno v:
J Clin Endocrinol Metab
Context Androgen prohormones such as dehydroepiandrosterone (DHEA) increase in early puberty, peak in the second and third decade, and thereafter decline, independent of menopausal status. Investigators have examined their potential beneficial effect
Autor:
Carmen Ruggiero, Mariangela Tamburello, Elisa Rossini, Silvia Zini, Nelly Durand, Giulia Cantini, Francesca Cioppi, Constanze Hantel, Katja Kiseljak‐Vassiliades, Margaret E. Wierman, Laura‐Sophie Landwehr, Isabel Weigand, Max Kurlbaum, Daniela Zizioli, Andrei Turtoi, Shengyu Yang, Alfredo Berruti, Michaela Luconi, Sandra Sigala, Enzo Lalli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6d85c275eecf785a48c9589bc5a3330
https://hdl.handle.net/11379/575085
https://hdl.handle.net/11379/575085
Autor:
Andrew J. H. Sedlack, Samual J. Hatfield, Suresh Kumar, Yasuhiro Arakawa, Nitin Roper, Nai-Yun Sun, Naris Nilubol, Katja Kiseljak-Vassiliades, Chuong D. Hoang, Emily K. Bergsland, Jonathan M. Hernandez, Yves Pommier, Jaydira del Rivero
Publikováno v:
Cancers. 15:2873
Adrenocortical cancer is an aggressive endocrine malignancy with an incidence of 0.72 to 1.02 per million people/year, and a very poor prognosis with a five-year survival rate of 22%. As an orphan disease, clinical data are scarce, meaning that drug